Required and undesired effects of gender affirming hormone therapy in people with gender dysphoria: a longitudinal cohort study
- Conditions
- F64.0F64.2TranssexualismGender identity disorder of childhood
- Registration Number
- DRKS00025399
- Lead Sponsor
- Medizinische Klinik 1, Schwerpunkt Endokrinologie-Diabetologie Universitätsklinikum Frankfurt
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
confirmed diagnosis of gender dysphoria
- referral of a trained mental health professional, attesting indication for gender affirming hormone therapy
Exclusion Criteria
- medical history of a relevant liver disease
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development of liver pathology as side effect of gender affirming hormone therapy.
- Secondary Outcome Measures
Name Time Method - cardiovascular and metabolic risk factors<br>- alteration of immunological parameters<br>- erythrocytosis under virilizing treatment<br>- alterations of body composition, muscularity and fitness<br>- subjective alterations of body perception, sexuality and muscularity